Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
59.65
+0.64 (1.08%)
Sep 3, 2026, 4:00 PM EDT - Market closed
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $4.37 billion as of September 3, 2026. Its market cap has increased by 253.20% in one year.
Market Cap
4.37B
Enterprise Value
3.48B
1-Year Change
253.20%
Ranking
Category
Stock Price
$59.65
ChartMarket Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $4.37B, an increase of 348.72%. That is a compound annual growth rate of 53.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 4.37B | 378.21% |
| Dec 31, 2025 | 913.95M | -16.86% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dyne Therapeutics | 4.69B |
| Edgewise Therapeutics | 4.59B |
| Celcuity | 4.50B |
| Legend Biotech | 4.09B |
| Veradermics | 4.07B |
| Relay Therapeutics | 4.05B |
| Viking Therapeutics | 3.93B |
| IDEAYA Biosciences | 3.85B |